BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35394553)

  • 1. Evaluation of a newly proposed renal risk score for Japanese patients with ANCA-associated glomerulonephritis.
    Saito M; Saito A; Abe F; Imaizumi C; Kaga H; Sawamura M; Nara M; Ozawa M; Sato R; Nakayama T; Okuyama S; Masai R; Ohtani H; Komatsuda A; Wakui H; Takahashi N
    Clin Exp Nephrol; 2022 Aug; 26(8):760-769. PubMed ID: 35394553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort study.
    Uchida T; Ichinose K; Yamashita A; Muta K; Kitamura M; Sato S; Iwamoto N; Nishino T; Kawakami A
    Front Immunol; 2023; 14():1141407. PubMed ID: 36926340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Wang R; Zhang X; Wang X; Chen L; Ma Q; Su Y; Liu J; Shi H
    Eur J Med Res; 2023 May; 28(1):164. PubMed ID: 37161465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of Berden's classification versus renal risk score for renal survival of Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kong W; Ni A; Wang M; Huang X; Chen L; Ma Y; Chen J; Han F
    Clin Exp Rheumatol; 2023 Apr; 41(4):893-901. PubMed ID: 36762743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the renal risk score for antineutrophil cytoplasmic antibody-associated glomerulonephritis in a Chinese population.
    Bai X; Guo Q; Lou Y; Nie P; Zhu Y; Li B; Luo P
    Clin Rheumatol; 2021 Dec; 40(12):5009-5017. PubMed ID: 34282511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a renal risk score in a cohort of children with ANCA-associated glomerulonephritis.
    Zhang P; Yao J; Gao CL; Fang X; Zhang ZQ; Xia ZK
    J Investig Med; 2023 Dec; 71(8):854-864. PubMed ID: 37615067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Antineutrophil Cytoplasmic Antibody Renal Risk Score and Modification of the Score in a Chinese Cohort With a Majority of Myeloperoxidase-Positive Patients.
    Ni A; Chen L; Lan L; Wang Y; Ren P; Zhu Y; Xu Y; Shen X; Zhou Q; Huang X; Wang H; Chen J; Han F
    J Rheumatol; 2023 May; 50(5):662-670. PubMed ID: 36642437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort.
    Berti A; Cornec-Le Gall E; Cornec D; Casal Moura M; Matteson EL; Crowson CS; Ravindran A; Sethi S; Fervenza FC; Specks U
    Nephrol Dial Transplant; 2019 Sep; 34(9):1508-1517. PubMed ID: 30102330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of interstitial change with renal prognosis in patients with myeloperoxidase-ANCA-associated glomerulonephritis: a single-center retrospective analysis.
    Kong W; Wang J; Wang M; Ni A; Huang X; Chen L; Zhou Q; Wang H; Chen J; Han F
    Clin Rheumatol; 2024 Jan; 43(1):377-386. PubMed ID: 37646859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Iwakiri T; Fujimoto S; Kitagawa K; Furuichi K; Yamahana J; Matsuura Y; Yamashita A; Uezono S; Shimao Y; Hisanaga S; Tokura T; Wada T; Kitamura K; Asada Y
    BMC Nephrol; 2013 Jun; 14():125. PubMed ID: 23773275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.
    Bjørneklett R; Sriskandarajah S; Bostad L
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2159-2167. PubMed ID: 27797896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of Japanese MPO-ANCA-related nephritis: significance of initial renal death for survival.
    Watanabe K; Tani Y; Kimura H; Tanaka K; Hayashi Y; Asahi K; Sato K; Sato M; Matsushima M; Nakayama M; Watanabe T
    Intern Med; 2012; 51(15):1969-76. PubMed ID: 22864120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.
    Chen Y; Bao H; Liu Z; Liu X; Gao E; Zeng C; Zhang H; Liu Z; Hu W
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):417-425. PubMed ID: 28148558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Tennstedt P; Vettorazzi E; Busch M; Nitschke M; Jabs WJ; Özcan F; Wendt R; Hausberg M; Sellin L; Panzer U; Huber TB; Waldherr R; Hopfer H; Stahl RAK; Wiech T
    Kidney Int; 2018 Dec; 94(6):1177-1188. PubMed ID: 30385041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Renal Risk Score and Histopathological Classification for Prediction of End-Stage Kidney Disease and Factors Associated With Change in eGFR After ANCA-Glomerulonephritis Diagnosis.
    Brilland B; Boud'hors C; Copin MC; Jourdain P; Henry N; Wacrenier S; Djema A; Samoreau C; Coindre JP; Cousin M; Riou J; Croue A; Saint-André JP; Subra JF; Piccoli GB; Augusto JF
    Front Immunol; 2022; 13():834878. PubMed ID: 35392077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis.
    Huang S; Shen Q; Yang R; Lai H; Zhang J
    Int Urol Nephrol; 2018 Oct; 50(10):1853-1861. PubMed ID: 30046964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.